Objective: The purpose of this study was to evaluate the technical feasibility and clinical efficacy of percutaneous transabdominal treatment of endoleaks after endovascular aneurysm repair.
ndoleaks represent one of the most common major complications encountered after endovascular aneurysm repair. Management of endoleaks remains somewhat controversial. Secondary intervention is mandatory in most cases with a type I endoleak because of the high risk of rupture (1, 2) . Usually, type II endoleaks with a growing aneurysm sac are treated, while those with a shrinking sac are observed (3) . However, the most effective methods for managing type II endoleaks are a matter of debate.
Transcatheter embolization of endoleaks is a less invasive treatment technique; it may provide a better approach to patient management than open surgical repair. Embolization can be performed through the transarterial approach or direct percutaneous puncture of the aneurysm sac via the translumbar (left side) or transcaval (right side) approaches. However, few cases of transabdominal embolization have been reported for repair of endoleaks (4) (5) (6) . In this study, we report our experience with embolization using a percutaneous transabdominal approach for the treatment of type I and II endoleaks. 
MATERIALS AND METHODS

Patient Group and Study Design
Between 2000 and 2007, 141 patients underwent endovascular aneurysm repair at our institution, and 33 endoleaks (23%) occurred. Based on follow-up imaging, the endoleaks were categorized as type I in 12 patients (9%), type II in 16 patients (11%), type III in two patients (1%), type IV in one patient (1%), and type V in two patients (1%). Initial treatment methods for the endoleaks are described in Table 1 . Among the 33 patients with endoleaks, six patients (five men, one woman; age range, 61-81 years; mean age, 68.2 years) with type I or type II endoleaks underwent embolization by the transabdominal approach using a liquid embolic agent, N-butyl cyanoacrylate. Five patients had an aortoiliac bifurcated stent-graft due to an infrarenal abdominal aortic aneurysm, and one patient (No. 3) had an aortoiliac bifurcated stent-graft due to a ruptured abdominal aortic aneurysm. Four patients had a type I endoleak, and two had a type II endoleak. Five patients underwent a single session and one patient (No. 1) underwent two sessions of embolization.
The indications for treatment of a type I or II endoleak, at our institution, were evidence of a type I endoleak during follow-up; or a type II endoleak with a significant increase in the diameter of the aneurysm sac (≥ 5 mm difference by CT in the largest minor axis cross-sectional diameter of the aneurysm sac). Indications for a transabdominal procedure included a type I endoleak with failed alternative endovascular options (n = 4; No. 1-4) and a type II endoleak located at the anterior aspect of the stentgraft with an enlarging endoleak sac (n = 2; No. 5, 6) Combined coil embolization was necessary in two patients to achieve repair of the endoleaks in cases of high-flow massive endoleaks from the attachment site (No. 3, 4) and in one case where the inferior mesenteric artery acted as an exit route for the endoleak (No. 3). Before the procedure, all patients received a medical evaluation and were determined to be good candidates for the transabdominal procedure. The median time between the endovascular aneurysm repair and embolization was 25.5 months (range: 0-84 months). The median follow-up after embolization was 16.4 months (range: 0-37 months).
Preoperative and Follow-Up Imaging
Before the endovascular aneurysm repair, patients underwent CT imaging including pre-contrast, arterial phase, and 30-second delayed contrast enhanced images. Patients had follow-up CT with the same protocol at 30 days; 3, 6, and 12 months; and yearly thereafter. The largest minor axis cross-sectional diameter of the aneurysm sac was measured. A size greater than or equal to a 5-mm difference, by the CT imaging, in the largest minor axis cross-sectional diameter of the aneurysm sac was considered clinically significant.
Percutaneous Transabdominal Embolization
Before percutaneous transabdominal embolization, preoperative aortography and selective angiography were performed via the transarterial approach. If treatment of the endoleak via the transarterial approach failed, a percutaneous transabdominal approach was immediately attempted. Before the procedure, intravenous prophylactic antibiotics (Cefazolin � 1 g [Yuhan Corp., Seoul, Korea] and Tobramycin 100 mg [Daewoong Pharmaceutical Co., Seoul, Korea]) were given. With the patient in the supine position, local anesthesia was administered at the puncture site of the abdomen. The target site was identified as a contrast-enhancing area of the aneurysm sac by CT (skin puncture point, puncture angle, depth of aneurysm sac from the skin) and color-flow ultrasound (US) guidance was used. The endoleak sac was punctured using a 21-gauge puncture needle (Chiba; Cook, Bloomington, IN) under fluoroscopic and/or color-flow US guidance. Bony landmarks and stent-graft marking bars were also referenced under fluoroscopic guidance. In case of bowel interposition at the anterior aspect of the aneurysm sac, the sigmoid and transverse colon were filled with barium, and the transabdominal approach was performed under fluoroscopic guidance to avoid colon injury. After confirmation of arterial blood flowing through the puncture needle, contrast media was injected to visualize the endoleak sac, a 0.018-inch guidewire was inserted, and the puncture tract was dilated. Over the 0.035-inch guide wire, a 5-Fr angiographic catheter was placed within the endoleak site, and an angiogram of the aneurysm sac was performed to evaluate the origin and outflow of the endoleak. Embolization of the endoleak sac and outflow vessels was performed. A 2.8-Fr microcatheter (Progreat; Terumo, Tokyo, Japan) was used when a more advanced endoleak selection was necessary or when the selection of outflow vessels was attempted. Before injection of N-butyl cyanoacrylate (Histoacryl, B. Braun, Tuttlingen, Germany), the catheter was flushed with 5% dextrose-water solution to prevent precipitation. N-butyl cyanoacrylate liquid adhesive was mixed with iodized oil (Lipiodol Ultra Fluid, Guerbet, Aulnay-sous-Bois, France), ranging from 25% to 50% depending on the amount and velocity of blood flow from the endoleak. After embolization, the puncture tract was embolized using the N-butyl cyanoacrylate mixture.
The endpoint of the procedure was the nonvisualization of blood flow within the aneurysm sac on a completion transarterial angiogram. Technical success was defined as successful embolization of the endoleak sac and complete resolution of the endoleak on completion angiography.
Clinical success was defined as complete resolution of the endoleak without enlargement of the aneurysm sac on follow-up CT. Figure 1 .
RESULTS
Technical
There were no procedure-related complications such as intraperitoneal bleeding, ischemic bowel injury, bowel perforation, or infection in the aneurysm sac or graft. Patient No. 3, an 81-year-old man who had a successful embolization, died eight months after the procedure due to sudden cardiac death that was unrelated to the procedure.
DISCUSSION
Compared with open repair of infrarenal abdominal aortic aneurysms, endovascular aneurysm repair is less invasive and results in significantly better perioperative outcomes, including fewer systemic complications, shorter operative time, lower use of postoperative mechanical ventilation, and shorter hospital stay, resulting in a lower risk of perioperative mortality (7, 8) . However, secondary interventions are common in patients after endovascular aneurysm repair, and new complications such as incomplete exclusion of blood flow to the aneurysm sac, defined as an endoleak by White et al. (9) , have led to the stent-graft procedure. Even though the technical innovation for of the stent-graft has been performed (10), correction of endoleaks is one of the major causes of secondary intervention during the primary admission or within 30 days of aneurysm repair (7) .
Clinical management of endoleaks varies according to the different types. Type I and III endoleaks require treatment without delay, but the efficacy of management for type II endoleaks is a subject of debate (3, (11) (12) (13) (14) . At our institution, type II endoleaks are treated only when the aneurysm sac has grown by 5 mm or more during followup. Conventional methods for the management of type I endoleaks are stent-graft extensions, cuffs, or Palmaz stents. Stent-graft extensions or cuffs can be applied only if sufficient native aorta is available proximally or distally to support the stent (15) (16) (17) . When conventional methods fail or devices are unavailable, N-butyl cyanoacrylate embolization via a transabdominal approach can be attempted before resorting to open surgical repair. The conventional approach for a type II endoleak is transarterial (18) (19) (20) . If transarterial approaches fail, translumbar or transcaval approaches are usually used (21) (22) (23) (24) (25) (26) (27) (28) . However, if the endoleak sac is located at the anterior aspect of the stent-graft, translumbar or transcaval approaches are less feasible, and a transabdominal approach may be warranted.
All four patients with a type I endoleak had secondary endovascular interventions to repair the type I endoleaks. A. Preprocedural CT showed type l endoleak (black arrows) within aneurysm sac. Inferior mesenteric artery (white arrow) was exit route for endoleak. Area previously treated with N-butyl cyanoacrylate via transarterial approach for repair of type l endoleak can be seen (asterisk). B. Digital subtraction angiography via transabdominal approach C showed type l endoleak (black arrow) with inferior mesenteric artery (white arrows). Embolization of endoleak sac using N-butyl cyanoacrylate was performed (not shown). C. One-month follow-up CT showed complete repair of type l endoleak with radiopaque N-butyl cyanoacrylate in place of previous endoleak sac. However, 1-year follow-up CT (not shown) showed increased diameter of aneurysm sac with indistinct type l endoleak and patient eventually underwent surgical conversion.
Two patients (No. 3, 4) had a sufficient margin for stentgraft extension. In patient No. 3, both an aortic extender cuff and a Palmaz stent were placed. In patient No. 4, an aortic extender cuff was placed. Two patients (No. 1, 2) had no margin for placement of an aortic extender cuff for the proximal type I endoleak, and no Palmaz stent was available; therefore, balloon percutaneous angioplasty was performed at the attachment site. These secondary endovascular interventions had failed to repair the type I endoleaks in all four patients with type I endoleaks. Transarterial embolization was attempted in two patients (No. 1, 2) as the next step. Patient No. 2 underwent transarterial embolization using N-butyl cyanoacrylate.
However, the type I endoleak recurred on the 3-month follow-up CT. The transarterial embolization of the endoleak sac failed in patient No. 1.
In two patients with a type II endoleak, transarterial embolization failed in patient No. 5 because of tortuous tracks from the internal iliac artery. In patient No. 6, a new type II endoleak developed despite previously successful transarterial embolization for the type II endoleak, on the 6-month follow-up CT. Open surgical repair or percutaneous transabdominal embolization was recommended for all six patients. Because their general condition was unfavorable for major surgery and they refused surgical repair, embolization of the aneurysm sac was performed. 
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The advantage of direct endoleak embolization by the translumbar or transcaval approach is that these methods avoid traversing cavities or organs (21) (22) (23) (24) (25) (26) (27) (28) (29) . Therefore, these approaches are ideal when an endoleak is located at the posterior aspect of the endovascular stent-graft or when bowel or another organ is interposed (27) . However, when the endoleak sac is located at the anterior aspect of the endovascular stent-graft, an anterior transabdominal approach is needed for embolization of the endoleak sac. The transabdominal approach has the advantage of being performed with the patient in the supine position, so that transarterial angiography can be performed simultaneously. Moreover, immediate confirmation of the angiography results and accurate targeting can be achieved. The risk of organ injury during the transabdominal approach can be minimized when performed under fluoroscopic and/or real-time US guidance.
There were two cases with clinical failure (No. 2, 4). Patient No. 2, who originally had a type I endoleak, underwent an aortic extender cuff placement for repair of a type I endoleak; however, a persistent type I endoleak was observed during follow-up on CT. For treatment of this endoleak, transarterial embolization was performed with insufficient exclusion of the endoleak. The transabdominal approach was performed for the next procedure and there was no visible endoleak on final aortography. However, increased diameter of the aneurysm sac was observed on the 1-year follow-up CT, raising the possibility of a recurrent type I endoleak. This case met our definition of a clinical failure, and surgical repair was recommended; at surgery, there was no definite evidence of an endoleak. We assumed that the cause of the increased diameter of the aneurysm sac was a type V endoleak or a subtle type I endoleak. Patient No. 4, who also originally had a type I endoleak, underwent aortic extender cuff placement for the repair of the type I endoleak; however, a persistent type I endoleak was noted during follow-up CT. When percutaneous transabdominal embolization was performed, the type I endoleak was not completely repaired and a patulous type I endoleak E. Digital subtraction angiography showed endoleak sac communicating with lumbar artery (arrows). Transabdominal approach was performed since main endoleak sac was located anteriorly. F. Embolization of endoleak sac was performed using N-butyl cyanoacrylate. G. 3-year follow-up CT demonstrated complete repair of type ll endoleak with radiopaque N-butyl cyanoacrylate in place of previous endoleak sac.
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resulted. A percutaneous approach was inappropriate in this case with a patulous type I endoleak. Surgical repair was recommended. The results of this study suggest that when treatment of an endoleak is considered necessary, and when the endoleak sac is located at the anterior aspect of the stentgraft, a percutaneous transabdominal approach to embolization under both color-flow US and fluoroscopic guidance is warranted. The percutaneous transabdominal procedure for the treatment of type I or II endoleaks after endovascular aneurysm repair is technically feasible and should be considered an alternative method when conventional endovascular methods have failed.
